Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2014
Filed with the SEC on Sep 2, 2014 and accepted by EDGAR at Sep 2, 2014, 17:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-05-01 to 2014-07-31 | $1.77bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2013-11-01 to 2014-07-31 | $5.18bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-05-01 to 2014-07-31 | $852.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2013-11-01 to 2014-07-31 | $2.48bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2014-05-01 to 2014-07-31 | $177.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2013-11-01 to 2014-07-31 | $530.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-05-01 to 2014-07-31 | $508.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2013-11-01 to 2014-07-31 | $1.51bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-05-01 to 2014-07-31 | $229.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2013-11-01 to 2014-07-31 | $657.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-05-01 to 2014-07-31 | $28.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2013-11-01 to 2014-07-31 | $87.0m | us-gaap:InterestExpense |
| Income tax | 3 months2014-05-01 to 2014-07-31 | $37.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2013-11-01 to 2014-07-31 | $80.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-05-01 to 2014-07-31 | $147.0m | us-gaap:ProfitLoss |
| Net income | 9 months2013-11-01 to 2014-07-31 | $481.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2014-05-01 to 2014-07-31 | $0.43 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2013-11-01 to 2014-07-31 | $1.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-05-01 to 2014-07-31 | $0.44 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2013-11-01 to 2014-07-31 | $1.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-05-01 to 2014-07-31 | 338,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2013-11-01 to 2014-07-31 | 338,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2013-11-01 to 2014-07-31 | $547.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2013-11-01 to 2014-07-31 | $162.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2013-11-01 to 2014-07-31 | $132.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2013-11-01 to 2014-07-31 | $200.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-07-31 | $2.39bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-07-31 | $4.83bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-07-31 | $10.38bn | us-gaap:Assets |
| Current liabilities | At period end2014-07-31 | $1.58bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-07-31 | $4.74bn | us-gaap:Liabilities |
| Long-term debt | At period end2014-07-31 | $2.18bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2014-07-31 | $35.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2014-07-31 | $5.64bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2014-07-31 | 333,512,738 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001090872-14-000024. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.